Effect of Sarpogrelate, a 5-HT2A Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study

Publisher： Karger

E-ISSN： 1421-9786|24|2-3|264-270

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.24, Iss.2-3, 2007-07, pp. : 264-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

THE EFFECT OF A 5HT 2 RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET FUNCTION IN BUERGER'S DISEASE

By Rydzewski A.   Urano T.   Hachiya T.   Kaneko H.   Baba S.   Takada Y.   Takada A.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 445-452

Elsevier

Access to resources Recommend Favorite

Variable Platelet Response to Aspirin in Patients with Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-05 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

Effect of Increasing Doses of Aspirin on Platelet Aggregation among Stroke Patients

By  

Cerebrovascular Diseases, Vol. 14, Iss. 3-4, 2002-10 ,pp. : 252-255

Karger

Access to resources Recommend Favorite

Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 28, Iss. 5, 2009-09 ,pp. : 505-513

Karger

Access to resources Recommend Favorite

Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT 2 antagonist (SR46349).

By Li Hui Y.   Callas D.   Fareed J.   Herbert J.M.  

Thrombosis Research, Vol. 81, Iss. 5, 1996-03 ,pp. : 555-567

Elsevier

Access to resources Recommend Favorite